Fulcrum Therapeutics
Price & Volume
Stats
See more52W Range | $2.49-$15.73 |
Market Cap | $521.4M |
Shares Short | 4M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | -100% |
Gross Profit (12 Mos) | -$56.1M |
Diluted EPS | -$1.18 |
News
See moreYahoo Finance • 20 days ago
MedicAlert Foundation, Sickle Cell Disease Association of America, Inc. (SCDAA), and Fulcrum Therapeutics Partner to Accelerate Emergency Department Access to Critical Care Information for People Living with Sickle Cell Disease
Yahoo Finance • last month
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance • last month
Fulcrum Therapeutics to Participate in the Leerink Partners Global Healthcare Conference
Yahoo Finance • last month
Fulcrum Therapeutics move lower ‘overdone,’ says Stifel
About
CEO | Mr. Alexander C. Sapir |
Address | 26 Landsdowne Street, Cambridge, MA, United States, 02139 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 55 |
